Rayid Abdulqawi

913 total citations · 1 hit paper
27 papers, 483 citations indexed

About

Rayid Abdulqawi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Rayid Abdulqawi has authored 27 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 8 papers in Physiology. Recurrent topics in Rayid Abdulqawi's work include Respiratory and Cough-Related Research (10 papers), Transplantation: Methods and Outcomes (7 papers) and Asthma and respiratory diseases (5 papers). Rayid Abdulqawi is often cited by papers focused on Respiratory and Cough-Related Research (10 papers), Transplantation: Methods and Outcomes (7 papers) and Asthma and respiratory diseases (5 papers). Rayid Abdulqawi collaborates with scholars based in United Kingdom, Saudi Arabia and United States. Rayid Abdulqawi's co-authors include John A. Smith, Rachel Dockry, Kimberley Holt, Bruce G. McCarthy, Gary Layton, Anthony Ford, Krishna Thavarajah, Kevin K. Brown, Daniel F. Dilling and Yoshikazu Inoue and has published in prestigious journals such as The Lancet, European Respiratory Journal and Thorax.

In The Last Decade

Rayid Abdulqawi

24 papers receiving 469 citations

Hit Papers

P2X3 receptor antagonist (AF-219) in refractory chronic c... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rayid Abdulqawi United Kingdom 6 364 273 77 72 59 27 483
David Muccino United States 11 408 1.1× 352 1.3× 43 0.6× 33 0.5× 122 2.1× 28 481
E. Waldkirch Germany 12 118 0.3× 46 0.2× 6 0.1× 40 0.6× 22 502
Fatemeh Malek Iran 11 104 0.3× 61 0.2× 17 0.2× 50 0.8× 30 332
D. Y. C. Yu Hong Kong 10 307 0.8× 331 1.2× 2 0.0× 17 0.2× 6 0.1× 16 560
Anna Miller United States 6 86 0.2× 64 0.2× 4 0.1× 29 0.4× 6 468
James C. Thompson United States 9 174 0.5× 69 0.3× 3 0.0× 8 0.1× 2 0.0× 13 562
Riken Chen China 11 118 0.3× 167 0.6× 2 0.0× 4 0.1× 3 0.1× 42 310
H.‐D. Allescher Germany 11 178 0.5× 41 0.2× 38 0.5× 2 0.0× 28 520
Dileep Unnikrishnan United States 6 49 0.1× 174 0.6× 3 0.0× 1 0.0× 3 0.1× 22 290
F. H. Vanmolkot Belgium 10 27 0.1× 111 0.4× 2 0.0× 31 0.4× 1 0.0× 12 337

Countries citing papers authored by Rayid Abdulqawi

Since Specialization
Citations

This map shows the geographic impact of Rayid Abdulqawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rayid Abdulqawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rayid Abdulqawi more than expected).

Fields of papers citing papers by Rayid Abdulqawi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rayid Abdulqawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rayid Abdulqawi. The network helps show where Rayid Abdulqawi may publish in the future.

Co-authorship network of co-authors of Rayid Abdulqawi

This figure shows the co-authorship network connecting the top 25 collaborators of Rayid Abdulqawi. A scholar is included among the top collaborators of Rayid Abdulqawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rayid Abdulqawi. Rayid Abdulqawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdulqawi, Rayid, Khaled Alkattan, Reem S. Almaghrabi, et al.. (2025). Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis Against Multidrug‐Resistant Bacteria. Transplant Infectious Disease. 27(3). e14446–e14446. 1 indexed citations
2.
Abdulqawi, Rayid, et al.. (2024). Lung Transplantation Outcomes of Patients with Pulmonary Alveolar Microlithiasis the Largest Series from a Single Centre Experience. The Journal of Heart and Lung Transplantation. 43(4). S443–S444. 1 indexed citations
4.
Abdulqawi, Rayid, et al.. (2024). Donor respiratory multidrug-resistant bacteria and lung transplantation outcomes. Journal of Infection. 88(2). 139–148. 5 indexed citations
5.
Kum, Elena, Gordon H. Guyatt, Rayid Abdulqawi, et al.. (2024). The McMaster Cough Severity Questionnaire (MCSQ): a cough severity instrument for patients with refractory chronic cough. European Respiratory Journal. 65(2). 2401565–2401565.
6.
Kum, Elena, Gordon Guyatt, Rayid Abdulqawi, et al.. (2024). Development of the McMaster Cough Severity Questionnaire (MCSQ): A Cough Severity Instrument for Patients With Chronic Cough. A7077–A7077. 1 indexed citations
7.
Abdulqawi, Rayid, et al.. (2023). Donor blood cultures and outcomes after lung transplantation: a single‐center report. Transplant Infectious Disease. 26(2). e14224–e14224. 2 indexed citations
8.
Abdulqawi, Rayid, et al.. (2023). Lung transplantation outcomes in underweight recipients: A single center experience. Heliyon. 9(4). e15080–e15080.
9.
Aldaoud, Najla, et al.. (2022). Precalcific phase of pulmonary alveolar microlithiasis. BMJ Case Reports. 15(7). e250370–e250370. 1 indexed citations
10.
Sabbah, Belal Nedal, et al.. (2022). Treatment of bronchial anastomotic fistula using autologous platelet-rich plasma post lung transplantation. Journal of Cardiothoracic Surgery. 17(1). 204–204. 8 indexed citations
11.
Abdulqawi, Rayid, et al.. (2021). An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough. ERJ Open Research. 7(3). 447–2021. 4 indexed citations
12.
Abdulqawi, Rayid, Imran Satia, Yoshihiro Kanemitsu, et al.. (2020). A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough. The Journal of Allergy and Clinical Immunology In Practice. 9(4). 1640–1647. 16 indexed citations
13.
Swigris, Jeffrey J., Kevin K. Brown, Rayid Abdulqawi, et al.. (2018). Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases. European Respiratory Review. 27(150). 180075–180075. 50 indexed citations
14.
Abdulqawi, Rayid, et al.. (2017). P148 Idiopathic pulmonary fibrosis: “lost in the system” in the north west of england?. HighWire Press Open Archive. A163–A164. 1 indexed citations
15.
Abdulqawi, Rayid, Rachel Dockry, Kimberley Holt, et al.. (2014). P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. The Lancet. 385(9974). 1198–1205. 349 indexed citations breakdown →
16.
Abdulqawi, Rayid, Rachel Dockry, Kimberley Holt, et al.. (2013). Inhibition of ATP-gated P2X3 channels by AF-219: An effective anti-tussive mechanism in chronic cough. 42. 1965. 6 indexed citations
17.
Smith, John A., Rayid Abdulqawi, & Lesley A. Houghton. (2011). GERD-Related Cough: Pathophysiology and Diagnostic Approach. Current Gastroenterology Reports. 13(3). 247–256. 12 indexed citations
18.
Abdulqawi, Rayid, et al.. (2008). Massive Retroperitoneal Adrenal Haemorrhage as the First Manifestation of a Lung Cancer. Annals of the Academy of Medicine Singapore. 37(7). 615–616. 4 indexed citations
19.
Abdulqawi, Rayid, et al.. (2008). Syrinx Associated with an Intramedullary Metastasis. Internal Medicine. 47(4). 329–330. 4 indexed citations
20.
Abdulqawi, Rayid, et al.. (2007). A rare cause of Sister Mary Joseph's nodule. Swiss Medical Weekly. 137(3940). 559–560. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026